LE MEDICAMENT DU MOIS. Vedolizumab (Entyvio(R)), nouveau traitement des maladies inflammatoires intestinales.

Article French OPEN
Van Kemseke, Catherine; Louis, Edouard; REENAERS, Catherine;
(2015)
  • Subject: Antibodies, Monoclonal, Humanized/pharmacology | Clinical Trials as Topic | Gastrointestinal Agents/pharmacology | Humans | Inflammatory Bowel Diseases/drug therapy | : Gastroenterology & hepatology [Human health sciences] | : Gastroentérologie & hépatologie [Sciences de la santé humaine]

Anti-TNF agents are highly effective in treating inflammatory bowel diseases, but loss of response and side-effects leading to drug interruption are often reported. New molecules are needed to treat these patients. Vedolizumab is a fully humanized anti-body inhibiting t... View more
Share - Bookmark